Milind Javle, MD, of MD Anderson Cancer Center, Houston, TX, discusses changes in the management in biliary tract cancer, in part due to next-generation sequencing and the identification of actionable mutations. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).